Deletion of Decay-Accelerating Factor (CD55) Exacerbates Autoimmune Disease Development in MRL/lpr Mice

This publication has 48 references indexed in Scilit:

• Complement
  New England Journal of Medicine, 2001
• Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2
  The Journal of Experimental Medicine, 2000
• The central and multiple roles of B cells in lupus pathogenesis
  Immunological Reviews, 1999
• Disruption of the Cr2 Locus Results in a Reduction in B-1a Cells and in an Impaired B Cell Response to T-Dependent Antigen
  Published by Elsevier ,1996
• C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity
  Science, 1996
• Polygenic control of susceptibility to murine systemic lupus erythematosus
  Immunity, 1994
• The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function
  Immunology Today, 1992
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
  Nature, 1992
• Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative Disease
  Annual Review of Immunology, 1991
• Decay-accelerating Factor in Human Skin Is Associated with Elastic Fibers
  Journal of Investigative Dermatology, 1988